Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Lithium Carbonate, and what generic alternatives are available?

Lithium Carbonate is a drug marketed by Hetero Labs Ltd Iii, Watson Labs, West-ward Pharms Int, Hikma Intl Pharms, Glenmark Generics, Mylan Pharms Inc, Able, Sun Pharm Inds Inc, Heritage Pharma, Pfizer, Usl Pharma, Glenmark Pharms Inc, Alembic Pharms Ltd, Alembic Ltd, Barr, Unique Pharm Labs, and Apotex Inc. and is included in twenty-eight NDAs.

The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.

Summary for Tradename: LITHIUM CARBONATE

Suppliers / Packagers: see list35
Bulk Api Vendors: see list55
Clinical Trials: see list155
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LITHIUM CARBONATE at DailyMed

Pharmacology for Tradename: LITHIUM CARBONATE

Drug ClassMood Stabilizer
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL076366-001Aug 21, 2003DISCNNoNo► Subscribe► Subscribe
Alembic Ltd
lithium carbonate
CAPSULE;ORAL079159-001Jan 12, 2009ABRXNoNo► Subscribe► Subscribe
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL076170-001Jun 10, 2002DISCNNoNo► Subscribe► Subscribe
Alembic Ltd
lithium carbonate
CAPSULE;ORAL079159-002Jan 12, 2009ABRXNoNo► Subscribe► Subscribe
Hetero Labs Ltd Iii
lithium carbonate
CAPSULE;ORAL090702-001Sep 25, 2009ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus